Braveheart Bio, Inc. · NASDAQ:BRVE
Jiangsu Hengrui Pharmaceuticals Co., Ltd. converted 7,420,091 Braveheart Bio, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 10, 2026
On Aug 7, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (10% owner) converted 7,420,091 Braveheart Bio, Inc. shares, leaving 7,420,091 shares. Filed Aug 10, 2026 (Form 4).
- Converted
- 7,420,091 shares
- Holding after
- 7,420,091 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Conversion | 7,420,091 | 7,420,091 | Direct |
Source
Related
- Braveheart Bio, Inc.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Braveheart Bio, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Sep 10, 2026
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13D · AH Bio Fund IV, L.P. · Aug 14, 2026
- Form 4 · Andreessen Marc L · Aug 11, 2026